齐拉西酮是一种非典型抗精神病药，其结构与吩噻嗪类或丁酞苯类抗精神病药物不同。体外研究显示，齐拉西酮对多巴胺D2, D3, 5-羟色胺5HT2A, 5HT2C、5HT1A、5HT1D、a-肾上腺素能受体具有较高的亲和力，对组胺H1受体具有中等亲和力，对包括M胆碱能受体在内的其他受试受体/结合位点未见亲和力。
盐酸齐拉西酮胶囊 Ziprasidone Hydrochloride Capsules ; Ziprasidone ; Ziprasidone Hydrochloride ; Ziprasi
盐酸齐拉西酮 ZiprasidoneHydrochloride ; Ziprasidone HCl ; ziprasitone hcl monohydrate ; Ziprasidone Hydrochloride
齐拉西酮. Ziprasidone ; Ziprasidone hydrochloride ; Zipras
甲磺酸齐拉西酮 Ziprasidone mesilate ; Exemestane
齐拉西酮胶囊 Ziprasidone Hydrochloride Capsules
盐酸齐拉西酮片 Ziprasidone Hydrochloride Tablets
甲磺酸齐拉西酮注射液 Ziprasidone Mesylate Injection
齐拉西酮甲磺酸盐 ZIPRASIDONE MESYLATE
注射用甲磺酸齐拉西酮 Ziprasidone Mesylate for Injection
Methods A total of 84 cases were divided into two groups randomly,tread with Ziprasidone and Risperidone respectively for 6 week.
方法将84例酒精所致精神障碍患者随机分为两组,分别用齐拉西酮与利培酮治疗6周。
参考来源 - 齐拉西酮与利培酮治疗酒精所致精神障碍的疗效观察Ziprasidone is a 5-HT and dopamine-receptor antagonist, especially 5-HT_(2A) and D_2 receptor.
齐拉西酮属5-羟色胺和多巴胺受体拮抗剂，特别是对5-HT A_2／D_A D_2受体亲合力强。
参考来源 - 1，3·2,447,543篇论文数据，部分数据来源于NoteExpress
目的：研究单剂量肌肉注射甲磺酸齐拉西酮后药动学。
OBJECTIVE: To study the pharmacokinetics of a single dose of intramuscularly injected ziprasidone mesylate in healthy volunteers.
结果齐拉西酮组总有效率为64.29%，明显高于利培酮组的42.85%。
Results The overall efficacy rate of ziprasidone (64.29%) was higher than that of risperidone (42.85%).
而且，自从第二代抗精神病药盐酸齐拉西酮获得美国食品药品监督局批准后，该药也被包括在内。
After its approval by the US Food and Drug Administration, the second-generation antipsychotic, ziprasidone hydrochloride, was also included.
应用推荐